The future has arrived #CUBETechFair

CUBE10 - 12 May 2017, Berlin, Germany.
Startups are setting up, speakers are tweaking their talks, and CUBE Tech Fair is ready for you... The inaugural CUBE Tech Fair kicks off tomorrow, and what a show they have for you. CUBE Tech Fair has brought the Crème de la Crème of the tech world to Berlin.

Over 300 startups from our ecosystem will be exhibiting, in addition to pitching for a €1 million prize in CUBE Challenge. The final round will be judged by Apple Co-Founder, Steve Wozniak.

Let's welcome keynote speeches by:

  • Pablos Holman (Founder of Intellectual Ventures Laboratory, notorious hacker)
  • Michael Müller (Mayor of Berlin)
  • Steve Wozniak (Co-Founder of Apple),
  • Robin Wright (Award-winning actress, tech activist),
  • Brigitte Zypries (Federal Minister of Economic Affairs and Energy)

The fireside chats, keynotes speeches, and panel discussions will deep-dive into specific industry areas. Topics include:

  • Infrastructure & Interconnectivity
  • Digital Health & Life Sciences
  • Machinery & Manufacturing
  • Cybersecurity & Hacking
  • Climate Change & Smart Energy Systems
  • Blockchain Innovations and more!

The Welcome Reception has filled up fast, and organisers already have exceptional guests including top startups, corporates and investors - and for good reason. Come, network and enjoy food tech at it's best - CUBE will be serving up bites from the incredible German Michelin-starred chef Christian Lohse. And on top of that all the ingredients are being provided by anti-food-waste startup SirPlus.

Don't have a booked seat? No problem! The event is still open to all Tech Fair badge holders!

On Thursday night, organisers take to the CityCube's terrace for the official Tech Fair party - they will of course be bringing Berlin's party spirit to the tech world.

Still don't have a ticket?! Get one now!

World Pharma News readers can benefit from an exclusive discount - get 30% off the ticket price using our unique promo code worldpharmanewsCUBE17 when you register online here.

About CUBE
CUBE is a Berlin-based global innovation ecosystem that aims to promote, create and foster partnerships between industry players and startups in life sciences & digital health, machinery & manufacturing as well as infrastructure & connectivity. Being part of the CUBE ecosystem allows all participants to collaborate on innovative products and ideas in response to concrete industry needs.

The annual CUBE Tech Fair, our flagship event, will take place for the first time in May 2017. For further information, please visit http://tech-fair.cube-global.com.

Most Popular Now

Pfizer and BioNTech complete submission to Europea…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the European Medicines Agency (EMA) for an Omicron-adapted biva...

Lilly will supply an additional 150,000 doses of b…

Eli Lilly and Company (NYSE: LLY) announced a modified purchase agreement with the U.S. government to supply an additional 150,000 doses of bebtelovimab for approximately...

Bayer to sell men's health product Nebido™ to Grün…

Bayer and Grünenthal have entered into a definitive agreement regarding the sale of Bayer's men's health product Nebido™ (testosterone undecanoate), for a purchase price ...

AstraZeneca to acquire TeneoTwo and its clinical-s…

AstraZeneca announced an agreement to acquire TeneoTwo, Inc. (TeneoTwo)i, including its Phase I clinical-stage CD19/CD3 T-cell engager, TNB-486, currently under evaluatio...

Demonstration of a potent, universal coronavirus m…

The SARS-CoV-2 that causes COVID-19 has killed 6.3 million people worldwide since 2019, painfully highlighting the vulnerability of humanity to novel coronaviruses. Re...

The fourth COVID-19 vaccine reduces the risk of de…

A new study by Tel Aviv University and Ben Gurion University of the Negev, in collaboration with the Israeli Ministry of Health, has found that the fourth COVID-19 vaccin...

Vaccine protection against COVID-19 short-lived, b…

Since COVID-19 vaccines first became available to protect against infection and severe illness, there has been much uncertainty about how long the protection lasts, and w...

Research shows investigational drug fosters nerve …

Scientists from the University of Birmingham have shown that a brain-penetrating candidate drug currently in development as a cancer therapy can foster regeneration of da...

NIH launches clinical trial of mRNA Nipah virus va…

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched an early-stage clinical trial evaluating an inv...

Anti-inflammatory compound shows potential in trea…

An anti-inflammatory compound may have the potential to treat systemic inflammation and brain injury in patients with severe COVID-19 and significantly reduce their chanc...

Vaccine-induced immune response to omicron wanes s…

Although COVID-19 booster vaccinations in adults elicit high levels of neutralizing antibodies against the Omicron variant of SARS-CoV-2, antibody levels decrease substan...

SARS-CoV-2 hijacks nanotubes between neurons to in…

COVID-19 often leads to neurological symptoms, such as a loss of taste or smell, or cognitive impairments (including memory loss and concentration difficulties), both dur...